Insider · CIK 0001776107

Brophy Gerard

Reports to the SEC for 1 company · RADNOR, PA

sec.gov

Transactions

Companies

Filings

CIK

0001776107

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-05-17	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−19.7K sh	$20.28	−$399K	89,032
2023-03-03	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−3,914 sh	$25.00	−$97.9K	108,715
2023-02-27	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−3,059 sh	$25.00	−$76.5K	112,629
2023-02-25	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−2,040 sh	$24.62	−$50.2K	115,688
2023-02-24	AVTRAvantor, Inc. · Stock Options (Right to Buy)A Award	EVP, Biopharma Production	AAward	+49.2K sh	—	—	49,215
2023-02-24	AVTRAvantor, Inc.A Award	EVP, Biopharma Production	AAward	+20.3K sh	—	—	117,728
2023-02-23	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−1,893 sh	$24.59	−$46.5K	97,420
2023-02-20	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−3,072 sh	$24.54	−$75.4K	99,313
2023-02-02	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−11.3K sh	$25.06	−$284K	102,385
2023-01-31	AVTRAvantor, Inc.A Award	EVP, Biopharma Production	AAward	+38.7K sh	—	—	128,945
2023-01-31	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−15.2K sh	$23.90	−$364K	113,724
2023-01-02	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−6,727 sh	$21.09	−$142K	90,208
2022-05-20	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−19.6K sh	$31.27	−$613K	96,935
2022-05-17	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−19.7K sh	$31.33	−$617K	116,538
2022-03-01	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−2,027 sh	$34.47	−$69.9K	136,221
2022-02-25	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−2,043 sh	$35.39	−$72.3K	138,248
2022-02-23	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−3,059 sh	$33.79	−$103K	125,181
2022-02-23	AVTRAvantor, Inc. · Stock Options (Right to Buy)A Award	EVP, Biopharma Production	AAward	+43.7K sh	—	—	43,708
2022-02-23	AVTRAvantor, Inc.A Award	EVP, Biopharma Production	AAward	+15.1K sh	—	—	140,291
2022-02-20	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−3,072 sh	$34.00	−$104K	128,240
2022-01-05	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−11.6K sh	$38.65	−$446K	131,312
2022-01-03	AVTRAvantor, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	−59.4K sh	—	—	59,417
2022-01-03	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−59.4K sh	$40.77	−$2.42M	142,863
2022-01-03	AVTRAvantor, Inc.M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	+59.4K sh	$18.45	+$1.1M	202,281
2022-01-02	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−6,516 sh	$42.14	−$275K	142,863
2021-07-30	AVTRAvantor, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	−81.1K sh	—	—	81,125
2021-07-30	AVTRAvantor, Inc.M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	+81.1K sh	$23.20	+$1.88M	230,504
2021-07-30	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−81.1K sh	$37.24	−$3.02M	149,379
2021-05-20	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−19.6K sh	$31.10	−$610K	149,379
2021-05-17	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−19.7K sh	$30.90	−$608K	168,982
2021-02-25	AVTRAvantor, Inc.A Award	EVP, Biopharma Production	AAward	+16.3K sh	—	—	188,665
2021-02-25	AVTRAvantor, Inc. · Stock Options (Right to Buy)A Award	EVP, Biopharma Production	AAward	+52.7K sh	—	—	52,693
2021-02-24	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−3,059 sh	$27.93	−$85.4K	172,384
2021-02-22	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−3,072 sh	$28.69	−$88.1K	175,443
2021-02-22	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−19.8K sh	$28.62	−$566K	175,443
2021-02-22	AVTRAvantor, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	−19.8K sh	—	—	59,306
2021-02-22	AVTRAvantor, Inc.M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	+19.8K sh	$17.67	+$349K	195,212
2021-01-11	AVTRAvantor, Inc.M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	+216K sh	$23.20	+$5.02M	394,847
2021-01-11	AVTRAvantor, Inc.M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	+162K sh	$23.20	+$3.76M	340,763
2021-01-11	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−216K sh	$30.08	−$6.51M	178,515
2021-01-11	AVTRAvantor, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	−162K sh	—	—	162,250
2021-01-11	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−162K sh	$30.04	−$4.87M	178,515
2021-01-06	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−11.5K sh	$27.24	−$314K	178,515
2021-01-04	AVTRAvantor, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	−59.4K sh	—	—	118,835
2021-01-04	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−59.4K sh	$27.84	−$1.65M	190,024
2021-01-04	AVTRAvantor, Inc.M Exercise/Conversion	EVP, Biopharma Production	MExercise/Conversion	+59.4K sh	$18.45	+$1.1M	249,442
2021-01-02	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−6,559 sh	$28.15	−$185K	190,024
2020-05-20	AVTRAvantor, Inc.S Sale	EVP, Biopharma Production	SSale	−25.5K sh	$17.36	−$443K	196,583
2020-05-17	AVTRAvantor, Inc.F Tax Payment	EVP, Biopharma Production	FTax Payment	−13.8K sh	$17.86	−$246K	222,078
2020-02-21	AVTRAvantor, Inc. · Stock Options (Right to Buy)A Award	EVP, Biopharma Production	AAward	+79.1K sh	—	—	79,075

Recent filings

Accepted (ET)
May 194
Brophy Gerard0001722482-23-000134
SEC(opens sec.gov)
Mar 64
Brophy Gerard0001722482-23-000081
SEC(opens sec.gov)
Mar 14
Brophy Gerard0001722482-23-000079
SEC(opens sec.gov)
Feb 274
Brophy Gerard0001722482-23-000075
SEC(opens sec.gov)
Feb 224
Brophy Gerard0001722482-23-000059
SEC(opens sec.gov)
Feb 24
Brophy Gerard0001722482-23-000023
SEC(opens sec.gov)
Jan 44
Brophy Gerard0001722482-23-000008
SEC(opens sec.gov)
May 234
Brophy Gerard0001722482-22-000147
SEC(opens sec.gov)
May 194
Brophy Gerard0001722482-22-000139
SEC(opens sec.gov)
Mar 24
Brophy Gerard0001722482-22-000067
SEC(opens sec.gov)
Feb 254
Brophy Gerard0001722482-22-000061
SEC(opens sec.gov)
Feb 224
Brophy Gerard0001722482-22-000044
SEC(opens sec.gov)

Companies

Avantor, Inc.EVP, Biopharma ProductionAVTR

Address

RADNOR CORPORATE CENTER, BUILDING ONE SUITE 200, 100 MATSONFORD ROAD

RADNOR, PA, 19087